作者
Maria Masulli,Lanfranco D’Elia,Fabio Angeli,Carlo M. Barbagallo,Giancarlo Bilancio,Michele Bombelli,Berardino Bruno,Edoardo Casiglia,Rosario Cianci,Arrigo F.G. Cicero,Massimo Círillo,Pietro Cirillo,Raffaella Dell’Oro,Giovambattista Desideri,Claudio Ferri,Loreto Gesualdo,Cristina Giannattasio,Guıdo Grassı,Guido Iaccarino,Luciano Lippa,Francesca Mallamaci,Alessandro Maloberti,Stefano Masi,Alberto Mazza,Alessandro Mengozzi,María Lorenza Muiesan,Pietro Nazzaro,Paolo Palatini,Gianfranco Parati,Roberto Pontremoli,Fosca Quarti‐Trevano,Marcello Rattazzi,Gianpaolo Reboldi,Giulia Rivasi,Massimo Salvetti,Valérie Tikhonoff,Giuliano Tocci,Andrea Ungar,Paolo Verdecchia,Francesca Viazzi,Agostino Virdis,Massimo Volpe,Claudio Borghi,Ferruccio Galletti
摘要
The URRAH (URic acid Right for heArt Health) Study has identified cut-off values of serum uric acid (SUA) predictive of total mortality at 4.7 mg/dl, and cardiovascular (CV) mortality at 5.6 mg/dl. Our aim was to validate these SUA thresholds in people with diabetes.The URRAH subpopulation of people with diabetes was studied. All-cause and CV deaths were evaluated at the end of follow-up. A total of 2570 diabetic subjects were studied. During a median follow-up of 107 months, 744 deaths occurred. In the multivariate Cox regression analyses adjusted for several confounders, subjects with SUA ≥5.6 mg/dl had higher risk of total (HR: 1.23, 95%CI: 1.04-1.47) and CV mortality (HR:1.31, 95%CI:1.03-1.66), than those with SUA <5.6 mg/dl. Increased all-cause mortality risk was shown in participants with SUA ≥4.7 mg/dl vs SUA below 4.7 mg/dl, but not statistically significant after adjustment for all confounders.SUA thresholds previously proposed by the URRAH study group are predictive of total and CV mortality also in people with diabetes. The threshold of 5.6 mg/dl can predict both total and CV mortality, and so is candidate to be a clinical cut-off for the definition of hyperuricemia in patients with diabetes.